| No (N=64) |
Yes (N=13) |
P-value | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 55.0 (9.98) | 56.4 (13.4) | 0.314 |
| Median [Min, Max] | 54.5 [30.0, 82.0] | 58.0 [24.0, 79.0] | |
| Operation_history | |||
| Direct_surgery | 49 (76.6%) | 4 (30.8%) | 0.00348 |
| Surgery_after_neoadjuvant | 15 (23.4%) | 9 (69.2%) | |
| Type | |||
| CCC | 1 (1.6%) | 0 (0%) | 0.847 |
| EC | 2 (3.1%) | 1 (7.7%) | |
| HGSC | 57 (89.1%) | 12 (92.3%) | |
| LGSC | 2 (3.1%) | 0 (0%) | |
| MC | 1 (1.6%) | 0 (0%) | |
| Missing | 1 (1.6%) | 0 (0%) | |
| Clinical_stage | |||
| I | 1 (1.6%) | 0 (0%) | 0.0915 |
| II | 4 (6.3%) | 0 (0%) | |
| III | 34 (53.1%) | 3 (23.1%) | |
| IV | 25 (39.1%) | 10 (76.9%) | |
| TMB_group | |||
| High | 2 (3.1%) | 2 (15.4%) | 0.266 |
| Low | 61 (95.3%) | 11 (84.6%) | |
| Missing | 1 (1.6%) | 0 (0%) | |
| Planting_metastasis | |||
| No | 5 (7.8%) | 1 (7.7%) | 1 |
| Yes | 59 (92.2%) | 12 (92.3%) | |
| Lymph.node_metastasis | |||
| No | 26 (40.6%) | 4 (30.8%) | 0.725 |
| Yes | 38 (59.4%) | 9 (69.2%) | |
| Type_group | |||
| HGSC | 57 (89.1%) | 12 (92.3%) | 1 |
| Non_HGSC | 7 (10.9%) | 1 (7.7%) |